V

VistaGen Therapeutics
D

VTGN

3.30000
USD
0.35
(11.86%)
مغلق
حجم التداول
28,514
الربح لكل سهم
-2
العائد الربحي
-
P/E
-2
حجم السوق
101,245,554
أصول ذات صلة
ABBV
ABBV
2.030
(0.99%)
206.710 USD
A
APVO
-0.07500
(-3.64%)
1.98500 USD
C
CLDX
0.555
(2.22%)
25.500 USD
GILD
GILD
-0.680
(-0.57%)
118.320 USD
M
MNKD
0.02000
(0.54%)
3.73500 USD
MRK
MRK
1.500
(1.81%)
84.250 USD
S
SUPN
0.535
(1.27%)
42.695 USD
T
TBPH
0.210
(1.62%)
13.140 USD
المزيد
الأخبار المقالات

العنوان: VistaGen Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.